Chronic Bronchitis is a common condition which is characterized by persistent cough, with expectoration for at least three months of the year for two consecutive years. It is more prevalent these days because of the exposure to both active and passive smoke, air pollution, occupational hazards etc; Prevalence is directly related to that of tobacco chewing, smoking and excess usage of biomass fuels especially in low and middle income countries.
INTRODUCTION
Chronic bronchitis is a major cause of concern towards health care worldwide, as the subjects are more and more exposed to atmospheric pollution, occupational dust, noxious gases, active and passive smoking. Inhalation of smoke causes hyper secretion of mucus in large airways and alterations in the small airways of the lung which results in the manifestations of chronic airway obstruction. Clinically persistent cough with copious expectoration, dyspnoea and recurrent respiratory infections are common. Chronic Bronchitis has the greater resemblance with Kaphaja Kasa with respect to nidanas like raja and dhuma sevana, vatakapha prakopaka ahara vihara, and lakshanas like kasa with kapha shteevana, shwasakrichrata, shukapurnagalasyata etc; 1 There is considerable overlap of clinical features of chronic bronchitis and pulmonary emphysema, as quite often the two conditions co exist. For the present study, cases of chronic bronchitis without emphysematous changes with Forced expiratory volume < 80 % are taken. In order to manage chronic bronchitis with special reference to kaphaja kasa, formulations like Pippalyadi Qwatha, Shatyadileha and Vasa Swarasa which are mentioned in the context of Kaphaja Kasa are taken and evaluated their combined efficacy in the management of Chronic Bronchitis.
Shatyadi Leha Ingredients
Shati, Ativisha, Musta, Karkatashringi, Haritaki, Shunti each 1 part. Prakshepaka Dravyas-Hingu and Saindhava, Anupana-Takrodaka.
Method of Procure and administration
Churna's of drugs are procured and prepared from NKCA pharmacy, Mysore, Karnataka, India. The above mentioned churnas of Shati, Ativisha, Musta, Karkatashringi, Haritaki, Shunti are mixed and made into a paste (leha) by adding Hingu and saindhavayukta Takrodaka. In this form, this yoga is made to lick by the patient and hence the name shatyadi leha.
Vasa Swarasa
It includes single drug Vasa.
Method of Procure
Fresh leaves of vasa were collected daily from GAMC herbal garden and swarasa was extracted.
Methods

Ethical clearance number: EC-2009/KC-6
Objectives of the Study
To evaluate the combined effect of Pippalyadi Qwata, Shatyadi Leha and Vasa Swarasa in the management of Chronic Bronchitis
Source of Data
Patients of either sex diagnosed to be suffering from Chronic Bronchitis were selected incidentally from OPD and IPD, GAMC and Hospital, Mysore, Karnataka, India and also patients from other referrals who fit into the diagnostic criteria were taken for the study.
Sampling Data
Patients were assigned into a single group consisting of 50 patients excluding dropouts.
Inclusion Criteria
· Patients between the age of 35-75 years were selected for the study. · Patients irrespective of Sex, religion, occupation were selected for the study.
· Patients with the signs and symptoms of Chronic Bronchitis were selected for the study. 
Exclusion Criteria
Research Design
Total 50 patients were assigned into single group. Data were collected as per the Performa of the case sheet. The study was an observational with pre and post test design.
Intervention
· Patients were administered with Pippalyadi Qwatha 15 ml TID after food along with 15 ml of ushna jala. · Shatyadi Leha 6 g TID after food along with 5-10 ml of Takrodaka · Vasa Swarasa 20 ml OD along with 6 ml of honey early morning in empty stomach. · Duration -48days Investigations · Spirometry-FEV1 (Before and After Treatment) · Chest X-ray · Blood-Hb%. TC, DC, ESR, AEC · Sputum for AFB Data regarding the above factors were collected before, during and at the end of the treatment. Improvement was graded and results were statistically analyzed using Contingency coefficient test, Chi square test and descriptive statistics using SPSS for windows software. Ab  0  0  1  4  4  0  2  3  13  12  15  12  13  28  31  25  22  26  41  40  Mi  0  2  2  9  12  18  17  12  26  35  28  30  32  20  16  23  27  22  9  8  Mo  9  37  6  32  30  27  31  32  11  3  6  8  5  2  3  2  1  2  0  2  Se  41  11  41  5  4 Cough In the present study it was observed that maximum of 41 (82.0 %) patients had Severe Cough, most of the times in 24 h with exhaustion and 9 (18.0 %) patients had Moderate Cough 3-4 times in 24 h without exhaustion before treatment. After the treatment, maximum of 25 (50.0 %) patients had no cough followed by 23 (46.0 %) patients with mild cough, 2 (4.0 %) patient with moderate cough and no patient had severe cough. The result on cough showed statistically highly significant with P value 0.000
Parameters of the Study
RESULTS
Sputum Production
In the present study it was observed that maximum of 37 (74.0 %) patients had moderate i.e., 20-50 ml/day sputum production, followed by 11 (22.0 %) patients with severe sputum production of more than 50 ml/day and 2 (4.0 %) patients had mild i.e., 5-20 ml/day sputum production, before treatment. On 48 th day, maximum of 27 (54.0 %) patients had mild sputum production, followed by 22 (44.0 %) patients with no sputum production, 1 (2.0 %) patient with moderate sputum production and no patient with severe sputum production. The result on Sputum production showed statistically highly significant with P value 0.000
Dyspnoea
In the present study it was observed that maximum of 41 (82.0 %) patients had severe dyspnoea, followed by 6 (12.0 %) patients with moderate dyspnoea, 2 (4.0 %) patient with mild dyspnoea and 1 (2.0 %) patient with no dypsnoea before treatment. On 48 th day, maximum of 26 (42.0) % patients had no dyspnoea followed by 22 (44.0 %) patients with mild dyspnoea, 2 (4.0 %) patient with moderate dyspnoea and no patient with severe dyspnoea. The result on Dyspnoea showed statistically highly significant with P value 0.000
Ronchi
In the present study it was observed that maximum of 32 (64.0 %) patients had moderate ronchi, followed by 9 (18.0 %) patients with mild ronchi, 5 (10.0 %) patients with severe ronchi and 4 (8.0 %) patients with no ronchi before treatment. On 48 th day, maximum of 41 (82.0 %) patients had no ronchi followed by 9 (18.0 %) patients with mild ronchi, no patient with moderate and severe ronchi. The result on Ronchi showed statistically highly significant with P value 0.000 Crepitation In the present study it was observed that maximum of 30 (60.0 %) patients had severe crepitations, followed by 12 (24.0 %) patients with mild crepitations, 4 (8.0 %) patients with severe crepitations and 4 (8.0 %) patients with no crepitations before treatment. On 48 th day, maximum of 40 (80.0 %) patients had no crepitations followed by 8 (16.0 %) patients with mild crepitations, 2 (4.0 %) patients with moderate crepitations and no patient had severe crepitation. The result on Crepitations showed statistically highly significant with P value 0.000 
DISCUSSION
Cough
The result on relief of cough showed statistically highly significant effect with P value 0.000. This might be due to anti-inflammatory and anti-oxidant action of the drugs in Pippalyadi Qwatha which reduces the inflammation in the airways. It might also be due to Vasa which help in the expectoration of mucus plugs. Abstinence from smoking also reduces the irritation to the bronchioles.
Sputum Production
The result on controlling Sputum production showed statistically highly significant effect with P value 0.000. This might be due to mucolytic expectorant action of Vasa, Shati, Kantakari, Bharangi which helps in thinning the tenacious mucus plugs and in easy expectoration.
Dyspnoea
The result on relief of dyspnoea showed statistically highly significance with P value 0.000. This might be due to relief from obstruction of airflow and reduction in airway narrowing due to bronchodilatory action of the drugs like vasa and by Bharangi and kantakari, present in pippalyadi Qwatha.
Ronchi and crepitation
The result on ronchi and crepitation showed statistically highly significance with P value 0.000. This might be due to relief from airway narrowing due to bronchodilatory effect of drugs and as most of the drugs in pippalyadiqwatha and shatyadileha have anti-oxidant and anti-inflammatory action, they prevents the further tissue damage and checks the progression of fibrosis.
Mean Respiratory Rate
The result on Mean Respiratory Rate showed statistically highly significance with P value 0.000. Increased Mean Respiratory rate was reduced to normal due to mucolytic, expectorant, anti inflammatory action of the drugs present in Pippalyadiqwatha and Shatyadileha which reduced the increased inspiratory resistance.
Mean Forced Expiratory Volume in 1 sec
The result on Mean Forced Expiratory Volume in 1 Sec showed statistically highly significance with P value 0.000. Observing the increase in FEV1 we can say that combination of formulations i.e. vasa swarasa, pippalyadiquatha and shatyadi leha helps in reducing the airway obstruction and thus in turn helps in improving the function of the lungs. 19 . They induce alterations in membrane dynamics and permeation characteristics in structurally and therapeutically diverse constituents of the drugs such as vasicine etc.
Probable mode of action
CONCLUSION
The study was an observational, which was conducted on 50 patients. Incidence was noticed more in the age group of 65-75 years. Maximum number of patients in the study had the history of smoking for minimum of 10 years. Statistically results on all parameters showed highly significant effect at the end of treatment with the value of 0.000, Out of 50 patients, 22 patients got marked relief, 26 patients got moderate relief and only 2 patients found no relief. Increase in FEV1 which is assessed by Spirometer along with marked reduction in symptoms suggests the improvement in lung function. Most of the drugs in Pippalyadi qwatha and shatyadi leha have anti-inflammatory and antioxidant action which complement with each other. Along with Vasa they have bronchodilator, mucolytic and anti-tussive action which reduces cough, sputum production and breathlessness. They also prevent tissue damage by checking the progression of inflammation in respiratory epithelium. Hence, the yogas Pippalyadi qwatha, Shatyadi leha and vasa swarasa together in combination are very effective in the management of chronic bronchitis.
